MDedge News >Conference News > AAN 2024 Ted Bosworth May 14, 2024 Two Novel Epilepsy Treatments Headed for Pivotal Trials DENVER — Two new drugs are headed toward pivotal trials after making their endpoints in phase 2 treatment-resistant epilepsy studies, while a first-in-humans study of an implantable product suggests a new direction for this disease,...